Dr. Mathew George Mathai, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5900 S. Lake Dr., Cudahy, WI 53110 Phone: 414-744-4000 Fax: 414-489-4022 |
Dr. Arturo Eduardo Eyzaguirre, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-744-4000 Fax: 414-489-4022 |
Florin Stuleanu, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-744-4000 Fax: 414-489-4022 |
Dr. George Mathai, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-744-4000 |
Ajitkumar Parekh, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-489-4024 |
News Archive
On any given day in the United States, about 1 in 31 hospital patients has at least one health-care-associated infection, according to the Centers for Disease Control and Prevention.
Cost-saving measures proposed by Gov. Scott Walker's administration to Family Care programs for frail elderly and people with disabilities are coming under fire ... County Executive Chris Abele said the county didn't have the staff to do "intensive prevention efforts" envisioned by the state reform ideas. ... The state's proposed sustainability modifications to the program include an emphasis on shifting clients from publicly financed help to "natural supports" - meaning a greater reliance on family members for care.
The Centers For Medicare & Medicaid Services on Wednesday awarded $306 million in bonuses to 23 states for enrolling more children in Medicaid. The move is meant to help offset the expense of covering more kids in the state-federal health care program.
An Arkansas judge fined the drug maker and a subsidiary for misleading doctors and the public on the risks involved with taking an anti-psychotic drug, Risperdal, and for marketing the drug for an off-label use to the state's Medicaid system.
By allowing states the flexibility to make key decisions, the administration avoided a "political hot potato" regarding essential benefits -; the medical benefits insurers must cover under the U.S. health care.
› Verified 9 days ago